Results 1 to 10 of about 395,984 (223)

Malignant hyperthermia [PDF]

open access: yesВестник медицинского института «Реавиз»: Реабилитация, врач и здоровье, 2022
Malignant hyperthermia manifests as hypermetabolism of striated voluntary muscle. Generally, this condition occurs during general anesthesia when inhalational anesthetics and succinylcholine are used.
S. N. Ionov   +2 more
doaj   +8 more sources

Malignant Hyperthermia

open access: yesJAI (Jurnal Anestesiologi Indonesia)
Malignant hyperthermia (MH) is a life-threatening clinical syndrome caused by hypermetabolism involving skeletal muscle. MH is very rare, but it is one of the causes of death in the operating room. MH is an autosomal dominant disease and can be triggered
Doni Fajri   +2 more
doaj   +8 more sources

Malignant hyperthermia [PDF]

open access: yesKorean Journal of Anesthesiology, 2012
Malignant hyperthermia (MH) is an uncommon, life-threatening pharmacogenetic disorder of the skeletal muscle. It presents as a hypermetabolic response in susceptible individuals to potent volatile anesthetics with/without depolarizing muscle relaxants ...
Dong-Chan Kim
doaj   +11 more sources

Malignant Hyperthermia in Slavonic cohort – clinical and genetic findings beyond standard diagnostics [PDF]

open access: yesOrphanet Journal of Rare Diseases
Background Malignant Hyperthermia (MH) is a rare, hereditary, life-threatening pharmacogenetic disorder. The genetic background of MH was identified only in approximately half of MH-susceptible (MHS) patients, differing between geographical areas ...
Martina Klincová   +11 more
doaj   +2 more sources

RYR1 mutations linked to malignant hyperthermia susceptibility are associated with phenotypic changes in human B-lymphocytes [PDF]

open access: yesFrontiers in Immunology
Ryanodine receptor 1 (RyR1) is a key intracellular Ca2+ release channel primarily expressed in skeletal muscle, but also in some immune cells.
Huiying Li   +12 more
doaj   +2 more sources

Malignant hyperthermia [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2007
Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic gases such as halothane, sevoflurane, desflurane and the depolarizing muscle relaxant succinylcholine ...
Pollock Neil   +4 more
doaj   +3 more sources

Malignant hyperthermia (literature review) [PDF]

open access: yesВестник анестезиологии и реаниматологии, 2023
The objective – to summarize the current literature data on the etiology, pathogenesis, diagnosis and treatment of malignant hyperthermia.   The search and analysis of literature data on malignant hyperthermia in the medical information systems PubMed ...
R. R. Tukhvatullina, N. V. Matinyan
doaj   +2 more sources

Humidity impacts volatile anesthetic and heat responses of malignant hyperthermia susceptible mice [PDF]

open access: yesSkeletal Muscle
Background Malignant Hyperthermia (MH) is characterized by life-threatening whole-body hyperthermic reactions triggered by volatile anesthetics in susceptible individuals.
Miao He   +9 more
doaj   +2 more sources

Malignant hyperthermia: patient undergoing limb debridement surgery—a case report [PDF]

open access: yesJournal of Medical Case Reports
Background Malignant hyperthermia is a rare but potentially fatal clinical emergency, primarily triggered by inhaled volatile anesthetics. It is associated with inherited autosomal-dominant skeletal muscle disorders and typically caused by mutations in ...
Zhixiang Geng   +6 more
doaj   +2 more sources

Malignant hyperthermia?or not? [PDF]

open access: yesAnaesthesia, 1985
Summary Some of the problems of diagnosis and management of malignant hyperthermia are discussed as illustrated by three case reports.
exaly   +3 more sources

Home - About - Disclaimer - Privacy